Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Reynolds

Showing results (51-60 of 187) with videos related to

Pageof 19
Sort By:
Schizophrenia Research|April 11, 1997
Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenicsC L Beasley, G P Reynolds
AIDS (London, England)|September 1, 1996
5-Hydroxytryptamine deficits in the caudate nucleus in AIDSG P Reynolds, A M Sardar
Lancet (London, England)|October 21, 1989
Increased brain 3-hydroxykynurenine in Huntington's diseaseG P Reynolds, S J Pearson
The New England Journal of Medicine|September 6, 1990
Brain GABA levels in asymptomatic Huntington's diseaseG P Reynolds, S J Pearson
Neuropharmacology|July 1, 1988
Depletion of monoamine transmitters by tetrabenazine in brain tissue in Huntington's diseaseS J Pearson, G P Reynolds
Journal of Neural Transmission. General Section|January 1, 1994
Neocortical neurotransmitter markers in Huntington's diseaseS J Pearson, G P Reynolds
European Journal of Pharmacology|October 20, 1992
Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissueS L Mason, G P Reynolds
Neuroscience Letters|February 24, 1995
Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementiaA M Sardar, G P Reynolds
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 1, 1976
A method for the estimation of 2-phenylethylamine in human urine by gas chromatographyG P Reynolds, D O Gray
Cellular and Molecular Neurobiology|December 1, 1992
Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem studyA J Nazarali, G P Reynolds
Pageof 19

Showing results (51-60 of 187) with videos related to

Sort By:
Pageof 19
Schizophrenia Research|April 11, 1997
Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenicsC L Beasley, G P Reynolds
AIDS (London, England)|September 1, 1996
5-Hydroxytryptamine deficits in the caudate nucleus in AIDSG P Reynolds, A M Sardar
Lancet (London, England)|October 21, 1989
Increased brain 3-hydroxykynurenine in Huntington's diseaseG P Reynolds, S J Pearson
The New England Journal of Medicine|September 6, 1990
Brain GABA levels in asymptomatic Huntington's diseaseG P Reynolds, S J Pearson
Neuropharmacology|July 1, 1988
Depletion of monoamine transmitters by tetrabenazine in brain tissue in Huntington's diseaseS J Pearson, G P Reynolds
Journal of Neural Transmission. General Section|January 1, 1994
Neocortical neurotransmitter markers in Huntington's diseaseS J Pearson, G P Reynolds
European Journal of Pharmacology|October 20, 1992
Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissueS L Mason, G P Reynolds
Neuroscience Letters|February 24, 1995
Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementiaA M Sardar, G P Reynolds
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 1, 1976
A method for the estimation of 2-phenylethylamine in human urine by gas chromatographyG P Reynolds, D O Gray
Cellular and Molecular Neurobiology|December 1, 1992
Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem studyA J Nazarali, G P Reynolds
Pageof 19